Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 4
1959 1
1961 3
1963 1
1967 1
1970 1
1980 2
1981 1
1982 1
1983 2
1984 5
1985 1
1986 5
1987 11
1988 12
1989 9
1990 15
1991 14
1992 17
1993 15
1994 20
1995 11
1996 16
1997 15
1998 14
1999 24
2000 17
2001 29
2002 12
2003 18
2004 22
2005 26
2006 29
2007 33
2008 30
2009 24
2010 32
2011 37
2012 48
2013 87
2014 68
2015 76
2016 63
2017 86
2018 91
2019 99
2020 124
2021 123
2022 130
2023 107
2024 113
2025 101

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,659 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care.
Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, Mazzone ES, Vitale M, Snyder B, Quijano-Roy S, Bertini E, Davis RH, Meyer OH, Simonds AK, Schroth MK, Graham RJ, Kirschner J, Iannaccone ST, Crawford TO, Woods S, Qian Y, Sejersen T; SMA Care Group. Mercuri E, et al. Among authors: vitale m. Neuromuscul Disord. 2018 Feb;28(2):103-115. doi: 10.1016/j.nmd.2017.11.005. Epub 2017 Nov 23. Neuromuscul Disord. 2018. PMID: 29290580 Free article. Review.
Human NK cells and cancer.
Cantoni C, Falco M, Vitale M, Pietra G, Munari E, Pende D, Mingari MC, Sivori S, Moretta L. Cantoni C, et al. Among authors: vitale m. Oncoimmunology. 2024 Jul 16;13(1):2378520. doi: 10.1080/2162402X.2024.2378520. eCollection 2024. Oncoimmunology. 2024. PMID: 39022338 Free PMC article. Review.
Revolutionising healing: Gene Editing's breakthrough against sickle cell disease.
Dimitrievska M, Bansal D, Vitale M, Strouboulis J, Miccio A, Nicolaides KH, El Hoss S, Shangaris P, Jacków-Malinowska J. Dimitrievska M, et al. Among authors: vitale m. Blood Rev. 2024 May;65:101185. doi: 10.1016/j.blre.2024.101185. Epub 2024 Mar 7. Blood Rev. 2024. PMID: 38493007 Free article. Review.
Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis.
Huang YV, Sun Y, Chou H, Wagner N, Vitale MR, Bayer AL, Xu B, Lee D, Lin Z, Branche C, Waliany S, Neal JW, Wakelee HA, Witteles RM, Nguyen PK, Graves EE, Berry GJ, Alcaide P, Wu SM, Zhu H. Huang YV, et al. Among authors: vitale mr. Circ Res. 2025 Feb 28;136(5):473-490. doi: 10.1161/CIRCRESAHA.124.325652. Epub 2025 Feb 11. Circ Res. 2025. PMID: 39931812 Free PMC article.
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.
Ascierto PA, Casula M, Bulgarelli J, Pisano M, Piccinini C, Piccin L, Cossu A, Mandalà M, Ferrucci PF, Guidoboni M, Rutkowski P, Ferraresi V, Arance A, Guida M, Maiello E, Gogas H, Richtig E, Fierro MT, Lebbe C, Helgadottir H, Queirolo P, Spagnolo F, Tucci M, Del Vecchio M, Cao MG, Minisini AM, De Placido S, Sanmamed MF, Mallardo D, Paone M, Vitale MG, Melero I, Grimaldi AM, Giannarelli D, Dummer R, Sileni VC, Palmieri G. Ascierto PA, et al. Among authors: vitale mg. Nat Commun. 2024 Jan 2;15(1):146. doi: 10.1038/s41467-023-44475-6. Nat Commun. 2024. PMID: 38167503 Free PMC article. Clinical Trial.
Advances in Melanoma and Skin Cancers.
Mallardo D, Basile D, Vitale MG. Mallardo D, et al. Among authors: vitale mg. Int J Mol Sci. 2025 Feb 21;26(5):1849. doi: 10.3390/ijms26051849. Int J Mol Sci. 2025. PMID: 40076483 Free PMC article.
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.
Grover P, Lo SN, Li I, Kuijpers AMJ, Kreidieh F, Williamson A, Amaral T, Dimitriou F, Placzke J, Olino K, Vitale MG, Saiag P, Gutzmer R, Allayous C, Olofsson Bagge R, Mattsson J, Asher N, Carter TJ, Meniawy TM, Lawless AR, Czapla JA, Warburton L, Gaudy-Marqueste C, Grob JJ, Collins RG, Zhang E, Kessels JI, Neyns B, Mehmi I, Hamid O, Julve M, Furness AJS, Margolin KA, Lev-Ari S, Ressler JM, Haque W, Khattak MA, Wicky A, Roberts-Thomson R, Arance A, Warrier G, Schollenberger MD, Parente P, Chatziioannou E, Lipson EJ, Michielin O, Weber JS, Hoeller C, Larkin J, Atkins MB, Essner R, Johnson DB, Sullivan RJ, Nathan P, Schachter J, Lebbe C, Ascierto PA, Kluger H, Rutkowski P, Dummer R, Garbe C, Lorigan PC, Burton E, Tawbi HA, Haanen J, Carlino MS, Menzies AM, Long GV. Grover P, et al. Among authors: vitale mg. Ann Oncol. 2025 Jul;36(7):807-818. doi: 10.1016/j.annonc.2025.03.021. Epub 2025 Apr 8. Ann Oncol. 2025. PMID: 40204154
1,659 results